CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Worldwide, over 10 million people are killed or hospitalized because of traumatic brain injury each year. About 90% of deaths occur in low- and middle-income countries. The condition mostly affects young adults, and many experience l...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dewan Yashbir, Komolafe Edward O, Mejía-Mantilla Jorge H, Perel Pablo, Roberts Ian, Shakur Haleema
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2012-06-01
Seri Bilgileri:Trials
Konular:
Antifibrinolytic
Clinical trial
Emergency care
Intracranial bleeding
Tranexamic acid
Traumatic brain injury
Online Erişim:http://www.trialsjournal.com/content/13/1/87
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller